SAMe-TT2R2评分：口服抗凝决策中对静脉血栓栓塞患者有用的工具？

数据集获取（Figshare）

• 源站标题：SAMe-TT2R2 Score: A Useful Tool in Oral Anticoagulation Decision-Making for Venous Thromboembolism Patients?
• DOI：10.6084/m9.figshare.7509836.v1
• 发布日期：2018-12-26
• 文件数：5 个
• 文件总体积：710.50 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/SAMe-TT2R2_Score_A_Useful_Tool_in_Oral_Anticoagulation_Decision-Making_for_Venous_Thromboembolism_Patients_/7509836

命令行下载

curl -L -o "2359-4802-ijcs-20180044-gf01.jpg" "https://ndownloader.figshare.com/files/13928525"
curl -L -o "2359-4802-ijcs-20180044-gf02.jpg" "https://ndownloader.figshare.com/files/13928531"
curl -L -o "2359-4802-ijcs-20180044-gf03.jpg" "https://ndownloader.figshare.com/files/13928537"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/13928543"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/13928549"

文件清单

• 2359-4802-ijcs-20180044-gf01.jpg（337.19 KB）
• 2359-4802-ijcs-20180044-gf02.jpg（121.84 KB）
• 2359-4802-ijcs-20180044-gf03.jpg（240.19 KB）
• Table_1.xls（5.63 KB）
• Table_2.xls（5.63 KB）

文件总体积 710.50 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Abstract Background: The SAMe-TT2R2 score was introduced to identify atrial fibrillation patients with a high risk of not achieving a good time in therapeutic range (TTR) during vitamin K antagonists (VKA) therapy. Objective: The aim of this study was to evaluate this score in venous thromboembolism (VTE) patients. Patients and methods: A retrospective cohort study of patients receiving care at the outpatient anticoagulation clinic of a tertiary care teaching hospital. Patients were classified as having low (score 0-1) or high risk (score ≥ 2) of not achieving a good TTR. The area under the ROC curve was calculated to assess the ability of the score to predict a TTR ≥ 65%. Adverse event-free survival curves according to the SAMe-TT2R2 score were calculated by the Kaplan-Meier method and compared by the log-rank test. A p-value < 0.05 was considered statistically significant. Results: We investigated 111 patients during a median follow-up of 2.3 (0.7-6.4) years. Mean age was 54.1 ± 15.7 years and 71 (64.0%) were women. Low- and high-risk groups had similar mean TTR (51.9 vs. 49.6%; p = 0.593). The two groups did not differ significantly in the percentage of patients achieving a TTR ≥ 65% (35.6 vs. 25.8%; p = 0.370). The c-statistic was 0.595 (p = 0.113) for TTR ≥ 65%. Adverse event-free survival during anticoagulation was also similar in both groups (p = 0.136). Conclusions: The SAMe-TT2R2 score does not seem to be a useful tool in oral anticoagulation decision-making for patients with VTE and should not be used in this setting.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.7509836.v1（source: https://scielo.figshare.com/articles/dataset/SAMe-TT2R2_Score_A_Useful_Tool_in_Oral_Anticoagulation_Decision-Making_for_Venous_Thromboembolism_Patients_/7509836）。